Genetron Health Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
993
- Investments
-
3
- Share Price
-
$4.03
- (As of Thursday Closing)
Genetron Health General Information
Description
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.
Contact Information
Website
www.genetronhealth.comCorporate Office
- 1-2/F, Building 11
- Zone 1, 8 Life Science Parkway, Changping District
- Beijing, 102206
- China
Corporate Office
- 1-2/F, Building 11
- Zone 1, 8 Life Science Parkway, Changping District
- Beijing, 102206
- China
Genetron Health Stock Performance
As of 28-Mar-2024, Genetron Health’s stock price is $4.03. Its current market cap is $127M with 31.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.03 | $4.02 | $2.08 - $4.05 | $127M | 31.6M | 51.1K | -$3.88 |
Genetron Health Financials Summary
As of 31-Dec-2022, Genetron Health has a trailing 12-month revenue of $96.6M.
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 55,426 | 55,426 | 400,642 | 980,133 |
| Revenue | 96,622 | 96,622 | 82,382 | 61,443 |
| EBITDA | (92,743) | (92,743) | (67,469) | (435,821) |
| Net Income | (120,038) | (120,038) | (76,852) | (444,235) |
| Total Assets | 141,366 | 141,366 | 238,091 | 301,517 |
| Total Debt | 22,983 | 22,983 | 11,608 | 18,930 |
Genetron Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Genetron Health Comparisons
Industry
Financing
Details
Genetron Health Competitors (4)
One of Genetron Health’s 4 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| Burning Rock | Formerly VC-backed | Guangzhou, China | ||||
| Fulgent Genetics | Corporation | El Monte, CA | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA |
Genetron Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Genetron Health Patents
Genetron Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022551688-A | Method for detecting tumor-specific gene mutation and methylation in ctdna | Active | 16-Oct-2019 | ||
| EP-4023795-A1 | Method for detecting mutation and methylation of tumor specific gene in ctdna | Pending | 16-Oct-2019 | ||
| US-20230272475-A1 | A method for detecting the mutation and methylation of tumor-specific genes in ctdna | Pending | 16-Oct-2019 | ||
| EP-4023795-A4 | Method for detecting mutation and methylation of tumor specific gene in ctdna | Pending | 16-Oct-2019 | ||
| JP-7614192-B2 | Method for detecting mutations and methylation of tumor-specific genes in ctdna | Active | 16-Oct-2019 | C12Q1/6886 |
Genetron Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Genetron Health Investments (3)
Genetron Health’s most recent deal was a Later Stage VC with Arima Genomics for . The deal was made on 22-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Arima Genomics | 22-Jan-2022 | Later Stage VC | Biotechnology | ||
| TellBio | 16-Mar-2021 | Early Stage VC | Biotechnology | ||
| ImmuQuad Biotech | 30-Dec-2020 | Corporate | Biotechnology |
Genetron Health ESG
Risk Overview
Risk Rating
Updated October, 12, 2021
24.68 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,912
Rank
Percentile
Healthcare
Industry
of 616
Rank
Percentile
Medical Services
Subindustry
of 114
Rank
Percentile
Genetron Health FAQs
-
When was Genetron Health founded?
Genetron Health was founded in 2015.
-
Where is Genetron Health headquartered?
Genetron Health is headquartered in Beijing, China.
-
What is the size of Genetron Health?
Genetron Health has 993 total employees.
-
What industry is Genetron Health in?
Genetron Health’s primary industry is Diagnostic Equipment.
-
Is Genetron Health a private or public company?
Genetron Health is a Public company.
-
What is the current stock price of Genetron Health?
As of 28-Mar-2024 the stock price of Genetron Health is $4.03.
-
What is the current market cap of Genetron Health?
The current market capitalization of Genetron Health is $127M.
-
What is Genetron Health’s current revenue?
The trailing twelve month revenue for Genetron Health is $96.6M.
-
Who are Genetron Health’s competitors?
Bio-Rad Laboratories, Burning Rock, Fulgent Genetics, and Guardant Health are competitors of Genetron Health.
-
What is Genetron Health’s annual earnings per share (EPS)?
Genetron Health’s EPS for 12 months was -$3.88.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
